While investors supported the sliver of promise offered when Eli Lilly and Co. said its Alzheimer’s drug may slow progression early in the disease, doctors weren’t as impressed, saying it could take years to find out for sure.
The Libertarian candidate for governor said he initially favored a state-run exchange to administer the federal health care law, but chose a joint venture with the federal government after meeting with the governor's staff.
Eli Lilly and Co. won a U.S. appeals court ruling that upholds the validity of a patent for the lung-cancer drug Alimta and blocks generic competition through 2017. Alimta generated $2.5 billion in sales last year.
A $100 million neuroscience center Indiana University officials say will offer a "one stop shop" for patients recovering from head and spinal injuries, strokes and other medical conditions is days away from opening its doors in Indianapolis.
The surprise positive effect shown by an experimental Alzheimer’s drug “excited” executives at Eli Lilly and Co., but it raised as many questions as it answered.
Eli Lilly and Co.’s experimental Alzheimer’s drug failed to meet its primary goals in two separate clinical trials. However, when the results of both trials were combined, the drug appeared to have slowed the decline of cognition in some patients.
Royal Capital Management LLC is calling for the ouster of WellPoint Inc. CEO Angela Braly in a letter to the health insurer, saying she has “failed miserably.”
Health Systems is on pace this year for nearly $50 million in revenue, up from $42 million last year and just $4.5 million eight years ago. The Indianapolis company processes claims for health insurers when patients receive out-of-network care.
The Food and Drug Administration has identified a southern Indiana farm that produced cantaloupes linked to a deadly salmonella outbreak and says the operation has recalled its melons.
Republican gubernatorial candidate Mike Pence is asking Gov. Mitch Daniels to reject a state-run health insurance exchange called for by the federal health care law.
The Humane Society of Indianapolis is ready to open its new Animal Welfare Center in Haughville, featuring a low-cost vaccination clinic. The group wants to raise $750,000 to add a low-cost spay-and-neuter clinic to the center.
Aetna joins rivals WellPoint Inc. and Cigna Corp. in making big acquisitions as the U.S. government expands medical coverage.
Odds are long that Eli Lilly and Co.’s leading Alzheimer’s drug will show positive results when its Phase 3 trial results are released within a few weeks, but even the smallest improvement in the cognitive impairment of test patients would be a home run for Lilly.
Eli Lilly and Co. will book about $790 million in pretax income in the third quarter thanks to an early payment from former drug development partner Amylin Pharmaceuticals.
Dr. Craig Brater, 66, has worked at the Indianapolis-based school for 26 years, including the past 12 as dean. The school is the second largest medical school in the nation and the only one in Indiana.
Pfizer Inc., Johnson & Johnson and Elan Corp. are ending most plans to develop an Alzheimer’s drug after a second trial failure. Eli Lilly is developing a similar treatment.
The feds may be gaining on GOP governors who've balked at carrying out a key part of the health care overhaul law. Opponents of the law say they won't set up new private health insurance exchanges. But increasingly it's looking like Washington will do it for them.
The city that brought the world Prozac and other neuroscience drugs is doubling down on brain research with a new $52 million research center near Methodist Hospital.
The investor drubbing sustained by Hill-Rom Holdings Inc. last week stemmed not so much from the new acquisition it announced as from the gloomy outlook in the North American hospital market.
Austerity and upheaval in Europe have not hurt Eli Lilly and Co.’s $4 billion-a-year drug business there, but the company is moving forward with plans to survive a coming swoon anyway.
